This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Sep 2;26(6):tay153.

doi: 10.1093/jtm/tay153.

What is the prospect of a safe and effective dengue vaccine for travellers?

Anna P Durbin¹, Duane J Gubler²

Affiliations

Affiliations

¹ International Health, Johns Hopkins Bloomberg School of Public Health, Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC), Baltimore, MD, USA.
² Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore. Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC).

PMID: 30657935
DOI: 10.1093/jtm/tay153

Editorial

What is the prospect of a safe and effective dengue vaccine for travellers?

Anna P Durbin et al. J Travel Med. 2019.

. 2019 Sep 2;26(6):tay153.

doi: 10.1093/jtm/tay153.

Authors

Anna P Durbin¹, Duane J Gubler²

Affiliations

¹ International Health, Johns Hopkins Bloomberg School of Public Health, Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC), Baltimore, MD, USA.
² Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore. Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC).

PMID: 30657935
DOI: 10.1093/jtm/tay153

No abstract available

PubMed Disclaimer

Similar articles

Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers.
Wilder-Smith A. Wilder-Smith A. J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay057. J Travel Med. 2018. PMID: 30016457 No abstract available.
Exploring the role of a recently licensed dengue vaccine in Australian travellers.
Thevarajan I, Torresi J, Simmons C. Thevarajan I, et al. Med J Aust. 2020 Feb;212(3):102-103.e1. doi: 10.5694/mja2.50471. Epub 2020 Jan 7. Med J Aust. 2020. PMID: 31909484 No abstract available.
The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
Pitisuttithum P, Bouckenooghe A. Pitisuttithum P, et al. Expert Rev Vaccines. 2016 Jul;15(7):795-8. doi: 10.1080/14760584.2016.1189331. Expert Rev Vaccines. 2016. PMID: 27171845 No abstract available.
Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.
Guy B, Jackson N. Guy B, et al. Nat Rev Microbiol. 2016 Jan;14(1):45-54. doi: 10.1038/nrmicro.2015.2. Epub 2015 Dec 7. Nat Rev Microbiol. 2016. PMID: 26639777 Review.
Dengue vaccines: state of the art.
Swaminathan S, Batra G, Khanna N. Swaminathan S, et al. Expert Opin Ther Pat. 2010 Jun;20(6):819-35. doi: 10.1517/13543771003767476. Expert Opin Ther Pat. 2010. PMID: 20384534 Review.

See all similar articles

Cited by

Imported dengue in Spain: a nationwide analysis with predictive time series analyses.
Redondo-Bravo L, Ruiz-Huerta C, Gomez-Barroso D, Sierra-Moros MJ, Benito A, Herrador Z. Redondo-Bravo L, et al. J Travel Med. 2019 Dec 23;26(8):taz072. doi: 10.1093/jtm/taz072. J Travel Med. 2019. PMID: 31608405 Free PMC article.
Dengue vaccine development: status and future.
Wilder-Smith A. Wilder-Smith A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):40-44. doi: 10.1007/s00103-019-03060-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31784763 Free PMC article. Review.
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Valdés I, Lazo L, Hermida L, Guillén G, Gil L. Valdés I, et al. Front Immunol. 2019 Aug 27;10:1956. doi: 10.3389/fimmu.2019.01956. eCollection 2019. Front Immunol. 2019. PMID: 31507591 Free PMC article. Review.
Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
Galula JU, Salem GM, Chang GJ, Chao DY. Galula JU, et al. Hum Vaccin Immunother. 2019;15(10):2328-2336. doi: 10.1080/21645515.2019.1643676. Epub 2019 Aug 23. Hum Vaccin Immunother. 2019. PMID: 31314657 Free PMC article. Review.
Dengue vaccine development by the year 2020: challenges and prospects.
Wilder-Smith A. Wilder-Smith A. Curr Opin Virol. 2020 Aug;43:71-78. doi: 10.1016/j.coviro.2020.09.004. Epub 2020 Oct 18. Curr Opin Virol. 2020. PMID: 33086187 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information